Bayer and Atara Biotherapeutics Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors

Go back to Bayer and Atara Biotherapeutics Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors
(NASDAQ: ATRA) Delayed: 10.51 +0.29 (2.84%)
Previous Close $10.22    52 Week High $40.80 
Open $10.20    52 Week Low $12.45 
Day High $10.71    P/E N/A 
Day Low $10.15    EPS $0.00 
Volume 45,296